Gedea Biotech AB

📍 Lund, Sweden🗓 Founded 2015👥 10 employees
Biotechnology🌐 gedeabiotech.com
Website LinkedIn
Gedea Biotech develops pHyph, an antibiotic-free, safe and effective treatment of vaginal infections. Vaginal infections affect at least 400 million women every year worldwide and the market is worth more than 1,5 billion USD. 67 % per cent of women with a vaginal infection choose an ineffective treatment because they do not know if it is a fungal or bacterial infection. pHyph will be the only treatment on the market targeting both bacterial and fungal vaginal infections, reducing the risk of choosing the wrong treatment.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Gedea Biotech AB founded?
Gedea Biotech AB was founded in 2015.
What industry is Gedea Biotech AB in?
Gedea Biotech AB operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Gedea Biotech AB based?
Gedea Biotech AB is headquartered in Lund, Sweden.